Insider filing · INSM
Sara Bonstein
Chief Financial Officer
profile →
Insmed Incorporated
INSM · Healthcare · 136 filings in 24 months
ticker →
Sara Bonstein sold $809K of Insmed Incorporated (INSM)
Executed Jan 6, disclosed Jan 8, 2 days later.
Value, as filed
$809K
4,642 sh across 3 lots
Executed
Jan 6
the trade date, as filed
Disclosed
Jan 8
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SBSara Bonstein (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Insmed Incorporated (INSM). The largest single filing was $961K of INSM (8,272 sh × $116.18, as filed), executed May 13.
The name
INSMHealthcare · Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sara Bonstein in INSM
INSMSALE
Insmed Incorporated
$246K2,404 sh × $102.27
Exec Jun 3
Filed Jun 5 · 5:30 PM ET INSMSALE Insmed Incorporated $961K
8,272 sh × $116.18
Exec May 13
Filed May 15 · 5:30 PM ET INSMSALE Insmed Incorporated $117K
748 sh × $156.34
Exec Feb 3
Filed Feb 4 · 5:30 PM ET INSMSALE Insmed Incorporated $6.0M
58,400 sh across 2 lots
Exec Jul 21 2025
Filed Jul 23 2025 · 5:30 PM ET INSMSALE Insmed Incorporated $5.5M
57,764 sh across 2 lots
Exec Jul 7 2025
Filed Jul 9 2025 · 5:30 PM ET INSMSALE Insmed Incorporated $5.9M
57,765 sh across 2 lots
Exec Jun 23 2025
Filed Jun 25 2025 · 5:30 PM ET INSMSALE Insmed Incorporated $5.1M
57,666 sh across 5 lots
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET INSMSALE Insmed Incorporated $113K
1,579 sh × $71.50
Exec Jun 3 2025
Filed Jun 4 2025 · 5:30 PM ET